Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Fertility awareness based methods for pregnancy prevention.

Urrutia RP, Polis CB.

BMJ. 2019 Jul 11;366:l4245. doi: 10.1136/bmj.l4245. No abstract available.

PMID:
31296535
2.

Corrigendum to "Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women" [Contraception 99 (2019) 199-204].

Heffron R, Achilles SL, Dorflinger LJ, Hapgood JP, Kiarie J, Polis CB, Steyn PS.

Contraception. 2019 Jul;100(1):88. doi: 10.1016/j.contraception.2019.05.014. No abstract available.

PMID:
31229224
3.

Global Contraceptive Failure Rates: Who Is Most at Risk?

Bradley SEK, Polis CB, Bankole A, Croft T.

Stud Fam Plann. 2019 Mar;50(1):3-24. doi: 10.1111/sifp.12085. Epub 2019 Feb 21.

4.

Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women.

Heffron R, Achilles SL, Dorflinger LJ, Hapgood JP, Kiarie J, Polis CB, Steyn PS.

Contraception. 2019 Apr;99(4):199-204. doi: 10.1016/j.contraception.2018.12.001. Epub 2018 Dec 18. Erratum in: Contraception. 2019 Jul;100(1):88.

5.

Effectiveness of Fertility Awareness-Based Methods for Pregnancy Prevention: A Systematic Review.

Peragallo Urrutia R, Polis CB, Jensen ET, Greene ME, Kennedy E, Stanford JB.

Obstet Gynecol. 2018 Sep;132(3):591-604. doi: 10.1097/AOG.0000000000002784. Erratum in: Obstet Gynecol. 2019 Feb;133(2):382.

PMID:
30095777
6.

There might be blood: a scoping review on women's responses to contraceptive-induced menstrual bleeding changes.

Polis CB, Hussain R, Berry A.

Reprod Health. 2018 Jun 26;15(1):114. doi: 10.1186/s12978-018-0561-0. Review.

7.

Published analysis of contraceptive effectiveness of Daysy and DaysyView app is fatally flawed.

Polis CB.

Reprod Health. 2018 Jun 25;15(1):113. doi: 10.1186/s12978-018-0560-1.

8.

Multiple contraceptive method use and prevalence of fertility awareness based method use in the United States, 2013-2015.

Polis CB, Jones RK.

Contraception. 2018 Sep;98(3):188-192. doi: 10.1016/j.contraception.2018.04.013. Epub 2018 Apr 25.

PMID:
29702082
9.

Severity and management of postabortion complications among women in Zimbabwe, 2016: a cross-sectional study.

Madziyire MG, Polis CB, Riley T, Sully EA, Owolabi O, Chipato T.

BMJ Open. 2018 Feb 10;8(2):e019658. doi: 10.1136/bmjopen-2017-019658.

10.

Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women's risk of HIV?

Polis CB, Achilles SL, Hel Z, Hapgood JP.

Contraception. 2018 Mar;97(3):191-197. doi: 10.1016/j.contraception.2017.12.003. Epub 2017 Dec 11. No abstract available.

11.

Modeling the impact of novel male contraceptive methods on reductions in unintended pregnancies in Nigeria, South Africa, and the United States.

Dorman E, Perry B, Polis CB, Campo-Engelstein L, Shattuck D, Hamlin A, Aiken A, Trussell J, Sokal D.

Contraception. 2018 Jan;97(1):62-69. doi: 10.1016/j.contraception.2017.08.015. Epub 2017 Sep 5.

12.

Hormonal contraceptive methods and HIV: research gaps and programmatic priorities.

Riley HEM, Steyn PS, Achilles SL, Bass E, Gray AL, Polis CB, Kiarie JN.

Contraception. 2017 Aug;96(2):67-71. doi: 10.1016/j.contraception.2017.05.015. Epub 2017 Jun 7. No abstract available.

13.

Incidence of induced abortion in Malawi, 2015.

Polis CB, Mhango C, Philbin J, Chimwaza W, Chipeta E, Msusa A.

PLoS One. 2017 Apr 3;12(4):e0173639. doi: 10.1371/journal.pone.0173639. eCollection 2017.

14.

Estimating infertility prevalence in low-to-middle-income countries: an application of a current duration approach to Demographic and Health Survey data.

Polis CB, Cox CM, Tunçalp Ö, McLain AC, Thoma ME.

Hum Reprod. 2017 May 1;32(5):1064-1074. doi: 10.1093/humrep/dex025.

15.

Levonorgestrel in contraceptives and multipurpose prevention technologies: does this progestin increase HIV risk or interact with antiretrovirals?

Polis CB, Phillips SJ, Hillier SL, Achilles SL.

AIDS. 2016 Nov 13;30(17):2571-2576. No abstract available.

16.

An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women.

Polis CB, Curtis KM, Hannaford PC, Phillips SJ, Chipato T, Kiarie JN, Westreich DJ, Steyn PS.

AIDS. 2016 Nov 13;30(17):2665-2683. Review.

17.

Typical-use contraceptive failure rates in 43 countries with Demographic and Health Survey data: summary of a detailed report.

Polis CB, Bradley SE, Bankole A, Onda T, Croft T, Singh S.

Contraception. 2016 Jul;94(1):11-7. doi: 10.1016/j.contraception.2016.03.011. Epub 2016 Mar 24.

18.

The safety of hormonal contraceptives for women living with HIV and their sexual partners.

Phillips SJ, Polis CB, Curtis KM.

Contraception. 2016 Jan;93(1):11-6. doi: 10.1016/j.contraception.2015.10.002. Epub 2015 Oct 26. Review.

PMID:
26515194
19.

Multipurpose prevention technologies for sexual and reproductive health: mapping global needs for introduction of new preventive products.

Schelar E, Polis CB, Essam T, Looker KJ, Bruni L, Chrisman CJ, Manning J.

Contraception. 2016 Jan;93(1):32-43. doi: 10.1016/j.contraception.2015.09.002. Epub 2015 Sep 16.

20.

Contraceptive methods and risk of HIV acquisition or female-to-male transmission.

Haddad LB, Polis CB, Sheth AN, Brown J, Kourtis AP, King C, Chakraborty R, Ofotokun I.

Curr HIV/AIDS Rep. 2014 Dec;11(4):447-58. doi: 10.1007/s11904-014-0236-6. Review.

21.

Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence.

Polis CB, Phillips SJ, Curtis KM, Westreich DJ, Steyn PS, Raymond E, Hannaford P, Turner AN.

Contraception. 2014 Oct;90(4):360-90. doi: 10.1016/j.contraception.2014.07.009. Epub 2014 Jul 23. Review.

22.

Progestin-only contraception: injectables and implants.

Jacobstein R, Polis CB.

Best Pract Res Clin Obstet Gynaecol. 2014 Aug;28(6):795-806. doi: 10.1016/j.bpobgyn.2014.05.003. Epub 2014 Jun 5. Review.

23.

Using measurements of unmet need to inform program investments for health service integration.

Malarcher S, Polis CB.

Stud Fam Plann. 2014 Jun;45(2):263-75. doi: 10.1111/j.1728-4465.2014.00388.x.

PMID:
24931079
24.

Preference for Sayana® Press versus intramuscular Depo-Provera among HIV-positive women in Rakai, Uganda: a randomized crossover trial.

Polis CB, Nakigozi GF, Nakawooya H, Mondo G, Makumbi F, Gray RH; Members of the Rakai Health Sciences Program Sayana Press study team.

Contraception. 2014 May;89(5):385-95. doi: 10.1016/j.contraception.2013.11.008. Epub 2013 Nov 15.

PMID:
24332432
25.

Assessing the effect of hormonal contraception on HIV acquisition in observational data: challenges and recommended analytic approaches.

Polis CB, Westreich D, Balkus JE, Heffron R; Participants of the 2013 HC-HIV Observational Analysis Meeting.

AIDS. 2013 Oct;27 Suppl 1:S35-43. doi: 10.1097/QAD.0000000000000036. Review.

26.

Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence.

Polis CB, Curtis KM.

Lancet Infect Dis. 2013 Sep;13(9):797-808. doi: 10.1016/S1473-3099(13)70155-5. Epub 2013 Jul 19. Review.

PMID:
23871397
27.

Cost-effectiveness of increased access to emergency contraceptive pills: probably not.

Raymond EG, Trussell J, Polis CB.

Contraception. 2013 Apr;87(4):504. doi: 10.1016/j.contraception.2012.11.013. Epub 2013 Jan 3. No abstract available.

PMID:
23290429
28.

Effect of hormonal contraceptive methods on HIV disease progression: a systematic review.

Phillips SJ, Curtis KM, Polis CB.

AIDS. 2013 Mar 13;27(5):787-94. doi: 10.1097/QAD.0b013e32835bb672. Review.

PMID:
23135169
29.

Hormonal contraceptive use and female-to-male HIV transmission: a systematic review of the epidemiologic evidence.

Polis CB, Phillips SJ, Curtis KM.

AIDS. 2013 Feb 20;27(4):493-505. doi: 10.1097/QAD.0b013e32835ad539. Review.

PMID:
23079808
30.

Modelling the global competing risks of a potential interaction between injectable hormonal contraception and HIV risk.

Butler AR, Smith JA, Polis CB, Gregson S, Stanton D, Hallett TB.

AIDS. 2013 Jan 2;27(1):105-113. doi: 10.1097/QAD.0b013e32835a5a52.

31.

Effect of injectable contraceptive use on response to antiretroviral therapy among women in Rakai, Uganda.

Polis CB, Nakigozi G, Ssempijja V, Makumbi FE, Boaz I, Reynolds SJ, Ndyanabo A, Lutalo T, Wawer MJ, Gray RH.

Contraception. 2012 Dec;86(6):725-30. doi: 10.1016/j.contraception.2012.05.001. Epub 2012 Jun 18.

32.

Abortion and mental health: guidelines for proper scientific conduct ignored.

Polis CB, Charles VE, Blum RW, Gates WH Sr.

Br J Psychiatry. 2012 Jan;200(1):76-7; discussion 78-9, author reply 79-80. doi: 10.1192/bjp.200.1.76. No abstract available.

PMID:
22215870
33.

Trends and correlates of hormonal contraceptive use among HIV-infected women in Rakai, Uganda, 1994-2006.

Polis CB, Gray RH, Lutalo T, Nalugoda F, Kagaayi J, Kigozi G, Kiwanuka N, Serwadda D, Wawer MJ.

Contraception. 2011 Jun;83(6):549-55. doi: 10.1016/j.contraception.2010.10.002. Epub 2010 Dec 3.

PMID:
21570553
34.

Facing the facts on advance provision of emergency contraception.

Polis CB, Raymond EG, Trussell J.

Contraception. 2010 Dec;82(6):579-80; author reply 579. doi: 10.1016/j.contraception.2010.04.015. Epub 2010 May 26. No abstract available.

PMID:
21074023
35.

Effect of hormonal contraceptive use before HIV seroconversion on viral load setpoint among women in Rakai, Uganda.

Polis CB, Gray RH, Bwanika JB, Kigozi G, Kiwanuka N, Nalugoda F, Kagaayi J, Lutalo T, Serwadda D, Wawer MJ.

J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):125-30. doi: 10.1097/QAI.0b013e3181fbcc11.

36.

Effect of hormonal contraceptive use on HIV progression in female HIV seroconverters in Rakai, Uganda.

Polis CB, Wawer MJ, Kiwanuka N, Laeyendecker O, Kagaayi J, Lutalo T, Nalugoda F, Kigozi G, Serwadda D, Gray RH.

AIDS. 2010 Jul 31;24(12):1937-44. doi: 10.1097/QAD.0b013e32833b3282.

37.

Coerced sexual debut and lifetime abortion attempts among women in Rakai, Uganda.

Polis CB, Lutalo T, Wawer M, Serwadda D, Kigozi G, Nalugoda F, Kiwanuka N, Gray R.

Int J Gynaecol Obstet. 2009 Feb;104(2):105-9. doi: 10.1016/j.ijgo.2008.10.002. Epub 2008 Nov 20.

PMID:
19022442
38.

Abortion and long-term mental health outcomes: a systematic review of the evidence.

Charles VE, Polis CB, Sridhara SK, Blum RW.

Contraception. 2008 Dec;78(6):436-50. doi: 10.1016/j.contraception.2008.07.005. Epub 2008 Sep 23. Review.

PMID:
19014789
39.

Male circumcision and prevention of HIV and sexually transmitted infections.

Gray RH, Wawer MJ, Polis CB, Kigozi G, Serwadda D.

Curr Infect Dis Rep. 2008 May;10(2):121-7.

PMID:
18462586
40.

The effect of male circumcision on sexual satisfaction and function, results from a randomized trial of male circumcision for human immunodeficiency virus prevention, Rakai, Uganda.

Kigozi G, Watya S, Polis CB, Buwembo D, Kiggundu V, Wawer MJ, Serwadda D, Nalugoda F, Kiwanuka N, Bacon MC, Ssempijja V, Makumbi F, Gray RH.

BJU Int. 2008 Jan;101(1):65-70.

41.

Advance provision of emergency contraception for pregnancy prevention: a meta-analysis.

Polis CB, Schaffer K, Blanchard K, Glasier A, Harper CC, Grimes DA.

Obstet Gynecol. 2007 Dec;110(6):1379-88. Review.

PMID:
18055735
42.

Impact of maternal HIV coinfection on the vertical transmission of hepatitis C virus: a meta-analysis.

Polis CB, Shah SN, Johnson KE, Gupta A.

Clin Infect Dis. 2007 Apr 15;44(8):1123-31. Epub 2007 Mar 7.

PMID:
17366462
43.

Population effect of increased access to emergency contraceptive pills: a systematic review.

Raymond EG, Trussell J, Polis CB.

Obstet Gynecol. 2007 Jan;109(1):181-8. Review.

PMID:
17197603

Supplemental Content

Loading ...
Support Center